Strategic consulting to life sciences clients focused on the development and commercialization of therapies closely integrated with analytics and market research

INTUS aids drug discovery and development by combining molecular profile ("omic") data with the most comprehensive maps of biological networks to generate network models that link disease to drug to patient. These models capture the changes to biological networks in disease or upon exposure to drug and are used to find drugs that revert cellular patterns of disease, identify side effect risks, and select patients most likely to respond to therapy. We integrate molecular and clinical response to optimize trial design and execution and inform program go/no-go decisions. Though our platform, we have identified drug and biomarker assets and therapeutic targets in oncology and degenerative diseases. We serve pharmaceutical clients and pursue discovery and development alliances to advance our assets and those of our partners.